Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.(CGON) | 2,221,474 | 2,221,474 | 0 | $57.76M | $89.48M | 34.57% | +$31.72M |
| RAPT Therapeutics, Inc. | 1,562,500 | 1,562,500 | 0 | $12.50M | $40.30M | 15.57% | +$27.80M |
| Centessa Pharmaceuticals plcADS | 1,253,379 | 1,314,019 | +60,640 | $16.47M | $31.86M | 12.31% | +$15.40M |
| Verastem, Inc.(VSTM) | 1,276,520 | 2,615,120 | +1,338,600 | $5.30M | $23.09M | 8.92% | +$17.79M |
| Alumis Inc. | 4,247,670 | 4,247,670 | 0 | $12.74M | $16.95M | 6.55% | +$4.21M |
| Denali Therapeutics Inc.(DNLI) | 0 | 1,000,000 | +1,000,000 | $0 | $14.52M | 5.61% | +$14.52M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 1,731,233 | 1,731,233 | 0 | $6.92M | $12.76M | 4.93% | +$5.83M |
| Akero Therapeutics, Inc. | 244,900 | 244,900 | 0 | $13.07M | $11.63M | 4.49% | -$1.44M |
| Kymera Therapeutics, Inc.(KYMR) | 146,332 | 146,332 | 0 | $6.39M | $8.28M | 3.20% | +$1.90M |
| Hinge Health, Inc.CL A(HNGE) | 135,000 | 135,000 | 0 | $6.99M | $6.63M | 2.56% | -$360.4K |
| Avidity Biosciences, Inc. | 40,000 | 40,000 | 0 | $1.14M | $1.74M | 0.67% | +$606.8K |
| CASI Pharmaceuticals, Inc.(CASIF) | 787,121 | 979,956 | +192,835 | $928.8K | $1.63M | 0.63% | +$697.9K |
| Allogene Therapeutics Inc | 2,875,357 | 0 | -2,875,357 | $3.25M | $0 | — | -$3.25M |
| Bicara Therapeutics Inc | 949,260 | 0 | -949,260 | $8.82M | $0 | — | -$8.82M |
| Cullinan Therapeutics, Inc.(CGEM) | 594,025 | 0 | -594,025 | $4.47M | $0 | — | -$4.47M |
| Edgewise Therapeutics, Inc.(EWTX) | 585,000 | 0 | -585,000 | $7.67M | $0 | — | -$7.67M |
| IDEAYA Biosciences, Inc.(IDYA) | 144,468 | 0 | -144,468 | $3.04M | $0 | — | -$3.04M |
| Spyre Therapeutics, Inc.(SYRE) | 70,000 | 0 | -70,000 | $1.05M | $0 | — | -$1.05M |
| Structure Therapeutics IncADS | 210,000 | 0 | -210,000 | $4.36M | $0 | — | -$4.36M |
| Viridian Therapeutics, Inc.(VRDN) | 1,974 | 0 | -1,974 | $27.6K | $0 | — | -$27.6K |
| Xenon Pharmaceuticals Inc.(XENE) | 160,000 | 0 | -160,000 | $5.01M | $0 | — | -$5.01M |